These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31540025)

  • 1. The Universal 3D QSAR Model for Dopamine D
    Zięba A; Żuk J; Bartuzi D; Matosiuk D; Poso A; Kaczor AA
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of novel dopamine D
    Zhang C; Li Q; Meng L; Ren Y
    J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.
    Peng Y; Keenan SM; Zhang Q; Kholodovych V; Welsh WJ
    J Med Chem; 2005 Mar; 48(5):1620-9. PubMed ID: 15743203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
    Wilcox RE; Huang WH; Brusniak MY; Wilcox DM; Pearlman RS; Teeter MM; DuRand CJ; Wiens BL; Neve KA
    J Med Chem; 2000 Aug; 43(16):3005-19. PubMed ID: 10956209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent haloperidol derivatives covalently binding to the dopamine D2 receptor.
    Schwalbe T; Kaindl J; Hübner H; Gmeiner P
    Bioorg Med Chem; 2017 Oct; 25(19):5084-5094. PubMed ID: 28666858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method.
    Pourbasheer E; Shokouhi Tabar S; Masand VH; Aalizadeh R; Ganjali MR
    SAR QSAR Environ Res; 2015 Jun; 26(6):461-77. PubMed ID: 26055215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.
    Möller D; Salama I; Kling RC; Hübner H; Gmeiner P
    Bioorg Med Chem; 2015 Sep; 23(18):6195-209. PubMed ID: 26299826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists.
    Teeter MM; Froimowitz M; Stec B; DuRand CJ
    J Med Chem; 1994 Sep; 37(18):2874-88. PubMed ID: 7915325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) studies on α(1A)-adrenergic receptor antagonists based on pharmacophore molecular alignment.
    Zhao X; Chen M; Huang B; Ji H; Yuan M
    Int J Mol Sci; 2011; 12(10):7022-37. PubMed ID: 22072933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
    Zhang H; Li H; Ma Q
    J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics.
    Kaczor AA; Jörg M; Capuano B
    J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
    Ge H; Zhang Y; Yang Z; Qiang K; Chen C; Sun L; Chen M; Zhang J
    Bioorg Med Chem; 2019 May; 27(10):2100-2111. PubMed ID: 30981605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3D QSAR study on a set of dopamine D4 receptor antagonists.
    Boström J; Böhm M; Gundertofte K; Klebe G
    J Chem Inf Comput Sci; 2003; 43(3):1020-7. PubMed ID: 12767161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model.
    Sukalovic V; Soskic V; Sencanski M; Andric D; Kostic-Rajacic S
    J Mol Model; 2013 Apr; 19(4):1751-62. PubMed ID: 23300056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations.
    Halim SA; Zaheer-ul-Haq
    Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New molecular surface-based 3D-QSAR method using Kohonen neural network and 3-way PLS.
    Hasegawa K; Matsuoka S; Arakawa M; Funatsu K
    Comput Chem; 2002 Nov; 26(6):583-9. PubMed ID: 12385475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action of a negative allosteric modulator at the dopamine D
    Draper-Joyce CJ; Verma RK; Michino M; Shonberg J; Kopinathan A; Klein Herenbrink C; Scammells PJ; Capuano B; Abramyan AM; Thal DM; Javitch JA; Christopoulos A; Shi L; Lane JR
    Sci Rep; 2018 Jan; 8(1):1208. PubMed ID: 29352161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists.
    Duan X; Zhang X; Xu B; Wang F; Lei M
    Chem Biol Drug Des; 2016 Jul; 88(1):142-54. PubMed ID: 26851125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.